Plasma levels of matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) in age-related macular degeneration

Eye

Volumn 22, Issue 6, 2008, Pages 855-859

  Chau, K Y ^a   Sivaprasad, S ^b   Patel, N ^b   Donaldson, T A ^a   Luthert, P J ^a   Chong, N V ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; OPHTHALMOSCOPY; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL NEOVASCULARIZATION;

EID: 45449091963     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6702722     Document Type: Article

References (28)

1. Vingerling JR, Dielemans I, Hofman A, Grobbee DE, Hijmering M, Kramer CF et al. The prevalence of age-related maculopathy in the Rotterdam study. Ophthalmology 1995; 102: 205-210.
2. Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 1995; 102: 1450-1460.
3. Klein R, Klein BE, Jensen SC, Meuer SM. The five-year incidence and progression of age-related maculopathy. Beaver Dam Eye Study Ophthalmol 1997; 104: 7-21.
4. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. Beaver Dam Eye Study Ophthalmol 1992; 99: 933-943.
5. Johnson LV, Anderson DH. Age-related macular degeneration and the extracellular matrix. N Engl J Med 2004; 351: 320-322.
6. Ng EW, Adamis AP. Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration. Can J Ophthalmol 2005; 40: 352-368.
7. Spraul CW, Lang GE, Grossniklaus HE, Lang GK. Histologic and morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in postmortem eyes with age-related macular degeneration and histologic examination of surgically excised choroidal neovascular membranes. Surv Ophthalmol 1999; 44: S10-S32.
8. Chong NH, Keonin J, Luthert PJ, Frennesson CI, Weingeist DM, Wolf RL et al. Decreased thickness and integrity of the macular elastic layer of Bruch's membrane correspond to the distribution of lesions associated with age-related macular degeneration. Am J Pathol 2005; 166 241-251.
9. Guo L, Hussain AA, Limb GA, Marshall J. Age-dependent variation in metalloproteinase activity of isolated human Bruch's membrane and choroid. Invest Ophthalmol Vis Sci 1999; 40: 2676-2682.
10. Kamei M, Hollyfield JG. TIMP-3 in Bruch's membrane: Changes during aging and in age-related macular degeneration. Invest Ophthalmol Vis Sci 1999; 40: 2367-2375.
11. Lambert V, Wielockx B, Munaut C, Galopin C, Jost M, Itoh T et al. MMP-2 and MMP-9 synergize in promoting choroidal neovascularization. FASEB J 2003; 17: 2290-2292.
12. Lambert V, Munaut C, Jost M, Noel A, Werb Z, Foidart JM et al. Matrix metalloproteinase-9 contributes to choroidal neovascularization. Am J Pathol 2002; 161: 1247-1253.
13. Mullins RF, Russell SR, Anderson DH, Hageman GS. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J 2000; 14: 835-846.
14. Blankenberg S, Rupprecht HJ, Poirier O, Bickel C, Smieja M, Hafner G et al. AtheroGene Investigators. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 2003; 107: 1579-1585.
15. Auge N, Maupas-Schwalm F, Elbaz M, Thiers JC, Waysbort A, Itohara S et al. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation. Circulation 2004; 110: 571-578.
16. Bird AC, Bressler NM, Bressler SB, Chisholm, IH, Coscas G, Davis MD et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 1995; 39: 367-374.
17. Farias E, Ranuncolo S, Cresta C, Specterman S, Armanasco, E, Varela M et al. Plasma metalloproteinase activity is enhanced in the euglobulin fraction of breast and lung cancer patients. Int J Cancer 2000; 89: 389-394.
18. Chung TW, Kim JR, Suh JI, Lee YC, Chang YC, Chung TH et al. Correlation between plasma levels of matrix metalloproteinase (MMP)-9/MMP-2 ratio and alpha-fetoproteins in chronic hepatitis carrying hepatitis B virus. J Gastroenterol Hepatol 2004; 19: 565-571.
19. Ohbayashi H. Matrix metalloproteinases in lung diseases. Curr Protein Pept Sci 2002; 3: 409-421.
20. Tchetverikov I, Ronday HK, Van El B, Kiers GH, Verzijl N, TeKoppele JM et al. MMP profile in paired serum and synovial fluid samples of patients with rheumatoid arthritis. Ann Rheum Dis 2004; 63: 881-883.
21. Kai H, Ikeda H, Yasukawa H, Kai M, Seki Y, Kuwahara F et al. Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol 1998; 32: 368-372.
22. Tayebjee MH, Lip GY, Blann AD, Macfadyen RJ. Effects of age, gender ethnicity, diurnal variation and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and -9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2. Thromb Res 2005; 115: 205-210.
23. Kleiner DE, Stetler-Stevenson WG. Quantitative zymography, detection of picogram quantities of gelatinases. Anal Biochem 1994; 218: 325-329.
24. Lorenzl S, Albers DS, Relkin N, Ngyuen T, Hilgenberg SL, Chirichigno J et al. Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease. Neurochem Int 2003; 43: 191-196.
25. Seddon JM, Gensler G, Milton RC, Klein ML, Rifai N. Association between C-reactive protein and age-related macular degeneration. JAMA 2004; 291: 704-710.
26. Beuche W, Yushchenko M, Mader M, Maliszewska M, Felgenhauer K, Weber F. Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis. Neuroreport 2000; 11: 3419-3422.
27. Okamoto T, Akaike T, Sawa T, Miyamoto Y, van der Vliet A, Maeda H. Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation. J Biol Chem 2001; 276: 29596-29602.
28. Girolamo F, Virgintino D, Errede M, Capobianco C, Bernardini N, Bertossi M et al. Involvement of metalloprotease-2 in the development of human brain microvessels. Histochem Cell Biol 2004; 122: 261-270.